Native Starch Market Trend 2025-2034: Revolutionary Technological Advancements In The Evolution Of Starch Solutions
The Business Research Company's Pharmaceuticals Native Starch Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034
LONDON, GREATER LONDON, UNITED KINGDOM, June 19, 2025 /EINPresswire.com/ -- The pharmaceuticals native starch market has seen substantial growth recently, escalating from $5.65 billion in 2024 to a projection of $6.17 billion in 2025 with a Compound Annual Growth Rate CAGR of 9.1%. Factors contributing to this escalation include a rising demand for natural excipients, expanding pharmaceutical production, growing preference for biocompatible ingredients, increased manufacturing of generic drugs, and increasing regulatory support for natural ingredients.
What Is The Projected Future Growth Of The Pharmaceuticals Native Starch Market Size?
The pharmaceuticals native starch market is expected to maintain strong growth over the next few years, climbing to $8.69 billion in 2029 with a CAGR of 8.9%. This forecasted growth can be attributed primarily to rising investment in pharmaceutical innovation, heightened focus on sustainable sourcing, expanding applications in new drug formulations, increasing demand for clean-label pharmaceutical products, and escalating healthcare expenditure in emerging markets. Additionally, key trends that are likely to impact the market in the forecast period include technological advancements in starch processing, innovations in drug delivery systems, developments in bio-based pharmaceutical ingredients, significant research and development in plant-based excipients, and the development of both solubility and stability solutions.
Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24376&type=smp
What Are The Key Drivers Propelling The Growth Of The Pharmaceuticals Native Starch Market?
The climbing prevalence of chronic diseases is likely to be a key growth driver for the pharmaceuticals native starch market. Chronic diseases are medical conditions that typically progress slowly and endure for more than a year. As the aging population continues to rise, so does the prevalence of these long-lasting conditions such as diabetes, cardiovascular diseases, arthritis, and cancer, which tend to become more common with age. Pharmaceuticals native starch proves instrumental in managing these chronic diseases by enhancing drug formulation stability, increasing bioavailability, enabling controlled drug release, supporting patient compliance, and ultimately, improving effectiveness and long-term management of these medical conditions.
What Key Player Strategies Are Driving The Pharmaceuticals Native Starch Market?
Major companies operating in the pharmaceuticals native starch market include Cargill Incorporated, Archer Daniels Midland Company, Ingredion Incorporated, Tereos SCA, Roquette Frères SA., AGRANA, Tate & Lyle Public Limited Company, Colorcon Inc., Grain Processing Corporation, Siam Modified Starch Co. Ltd., BENEO GmbH, Gulshan Polyols Ltd., SPAC Starch Products India Private Limited, Universal Starch-Chem Allied Ltd., Sanstar Biopolymers Ltd., Emsland Group, Hungrana Kft., Bluecraft Agro Pvt. Ltd., Visco Starch, Shandong Liujia Pharmaceutical Excipient Co.Ltd.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/pharmaceuticals-native-starch-global-market-report
What Are The Emerging Trends In The Pharmaceuticals Native Starch Market?
Key players in the pharmaceuticals native starch market are pioneering innovative products such as plant-based textures to enhance drug formulations and improve patient compliance. These physical properties derived from plant ingredients enhance tablet binding, disintegration, and mouthfeel for improved natural drug formulations.
How Is The Pharmaceuticals Native Starch Market Segmented?
The pharmaceuticals native starch market is classified into five key segments:
1 By Type: Potato Starch, Corn Starch, Other Types
2 By Formulation Type: Oral Solid Dosage Forms, Liquid Dosage Forms, Topical Formulations, Injectable Drugs, Controlled Release Formulations
3 By Functionality: Texturizing Agent, Moisture Retention Agent, Bulking Agent, Emulsifying Agent, Film-Forming Agent
4 By Application: Binders And Coating Agents, Disintegrants, Fillers And Extenders, Stabilizers, Thickening Agents
5 By End-User: Pharmaceutical Manufacturers, Contract Research Organizations CROs, Contract Manufacturing Organizations CMOs, Research And Development Labs, Academic Institutions, Other End-users
Additionally, subsegments include:
1 By Potato Starch: Modified Potato Starch, Native Potato Starch
2 By Corn Starch: Modified Corn Starch, Native Corn Starch
3 By Other Types: Rice Starch, Wheat Starch, Tapioca Starch
What Are The Regional Insights In The Pharmaceuticals Native Starch Market?
North America led the pharmaceuticals native starch market in 2024. However, Asia-Pacific is expected to be the fastest-growing region in the forthcoming years. Regions covered in the report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
Browse Through More Similar Reports By The Business Research Company:
Radiopharmaceuticals Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/radiopharmaceutical-global-market-report
Generic Pharmaceuticals Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/generic-pharmaceuticals-global-market-report
Pharmaceuticals Market
https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market
About The Business Research Company
Learn More About The Business Research Company. With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info|tbrc.info| |info|tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

MLS Now is Improving Real Estate Agent Transparency with Rayse
Ned Markey Achieves Amazon Best-Seller Status with “Flip the Script” Book Co-Authored with Chris Voss
2025 Global Engineering & Science Award Winners – Cycle A & B
Więcej ważnych informacji
Jedynka Newserii

Jedynka Newserii

Polityka

D. Joński: Nie wiemy, co zrobi Rosja za dwa–trzy lata. Według duńskiego wywiadu może zaatakować kraje nadbałtyckie i musimy być na to gotowi
Zdecydowana większość krajów unijnych wskazuje na potrzebę wzmocnienia zdolności obronnych Europy w obliczu coraz bardziej złożonego geopolitycznego tła. Wywiady zachodnich państw wskazują, że Rosja może rozpocząć konfrontację z NATO jeszcze przed 2030 rokiem. Biała księga w sprawie obronności europejskiej „Gotowość 2030” zakłada m.in. ochronę granic lądowych, powietrznych i morskich UE, a sztandarowym projektem ma być Tarcza Wschód. – W budzeniu Europy duże zasługi ma polska prezydencja – ocenia europoseł Dariusz Joński.
Transport
Duże magazyny energii przyspieszą rozwój transportu niskoemisyjnego w Europie. Przyszłością może być wodór służący jako paliwo i nośnik energii

Zmiany w europejskim transporcie przyspieszają. Trendem jest elektromobilność, zwłaszcza w ramach logistyki „ostatniej mili”. Jednocześnie jednak udział samochodów w pełni elektrycznych w polskich firmach spadł z 18 do 12 proc., co wpisuje się w szerszy europejski trend spowolnienia elektromobilności. Główne bariery to ograniczona liczba publicznych stacji ładowania, wysoka cena pojazdów i brak dostępu do odpowiedniej infrastruktury. – Potrzebne są odpowiednio duże magazyny taniej energii. Przyszłością przede wszystkim jest wodór – ocenia Andrzej Gemra z Renault Group.
Infrastruktura
W Polsce w obiektach zabytkowych wciąż brakuje nowoczesnych rozwiązań przeciwpożarowych. Potrzebna jest większa elastyczność w stosowaniu przepisów

Pogodzenie interesów konserwatorów, projektantów, inwestorów, rzeczoznawców i służby ochrony pożarowej stanowi jedno z największych wyzwań w zakresie ochrony przeciwpożarowej obiektów konserwatorskich. Pożary zabytków takich jak m.in. katedra Notre-Dame w Paryżu przyczyniają się do wprowadzania nowatorskich rozwiązań technicznych w zakresie ochrony przeciwpożarowej. W Polsce obowiązuje już konieczność instalacji systemów detekcji. Inwestorzy często jednak rezygnują z realizacji projektów dotyczących obiektów zabytkowych z uwagi na zmieniające się i coraz bardziej restrykcyjne przepisy czy też względy ekonomiczne.
Partner serwisu
Szkolenia

Akademia Newserii
Akademia Newserii to projekt, w ramach którego najlepsi polscy dziennikarze biznesowi, giełdowi oraz lifestylowi, a także szkoleniowcy z wieloletnim doświadczeniem dzielą się swoją wiedzą nt. pracy z mediami.